Sometimes you can do everything right and still end up on the wrong side of a trade. And that seems to be the case for small-cap medical technology company SonoSite (Nasdaq:SONO). While this producer of portable ultrasound systems has solid current growth and strong prospects for future expansion, investors have turned more cautious on this company.

Bright Summer Followed by a Bleak Winter
SonoSite reported that revenue grew 23% for the recent quarter, with U.S. revenue up 18% and overseas revenue up 30%. Gross margins improved slightly and operating income came in solid, as the company has transitioned past the point of covering ongoing SG&A expenses.

Medical technology companies like Intuitive Surgical (Nasdaq:ISRG), Varian (NYSE:VAR) and Stryker (NYSE:SYK) have faced some challenges as a result of the declining health of the hospitals market. While these companies have not reported significant problems in ordering trends, the combined credit crunch and economic downturn could undercut medical capital spending.

SonoSite management acknowledged concerns over a slowdown in the hospitals sector, but it appears that an availability of credit is not a choking point at this time. Instead, some hospitals are freezing spending across the board.

Although portable ultrasound systems are not expensive enough to require the same level of management oversight and hospital board review as other high-end imaging systems producers like General Electric (NYSE:GE), Royal Philips (NYSE:PHG) and Siemens (NYSE:SI), a spending freeze is still a spending freeze. Thus, even if hospital administrators have the budget for SonoSite systems, they may be forced to postpone actual purchases.

Bigger Problems Afoot?
SonoSite had little say about the recent departure of CFO Bernard Pitz, which was brought about "at the request of the company". It is unclear whether Pitz's departure is tied to the company's failed attempt to complete an acquisition, but a drastic change in upper level management and a failed acquisition both equal sour news for SonoSite.

Competition could be seen as an even bigger problem for the company, however. SonoSite has the unenviable task of competing with the aforementioned GE, Philips and Siemens - vastly larger companies that have substantially higher advertising and promotional budgets to rely on. Furthermore, SonoSite's competitors can offer bundled deals across a wide array of products, whereas SonoSite is limited to portable ultrasound. Smaller companies sometimes are nimbler and more opportunistic. However, they often end up getting squashed under the feet of giants, despite any strong suits.

The Bottom Line
Even if SonoSite's growth slows significantly in 2009, there is a substantial difference between "slow" and "stop". Shares of SonoSite stock trade at a price-to-sales ratio of about 1.6, which is well below the usual range for growing small-cap and mid-cap medical technology stocks of 3 to 6. While the company has more debt than is normal for a med-tech company, which likely will grow as a result of new accounting rules for convertible bonds, SonoSite is using its solid free cash flow to pay down some of its debt early. Thus, at only a few dollars above the 52-week low, and with ample growth prospects, SonoSite is worth a look for investors in the growth-at-a-reasonable-price crowd.

To delve more deeply into these topics, read Use Price-to-Sales Ratios to Value Stocks and Free Cash Flow: Free, But Not Always Easy.

Related Articles
  1. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  2. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  3. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  4. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  5. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  6. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  7. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
  8. Investing News

    A 2016 Outlook: What January 2009 Can Teach Us

    January 2009 and January 2016 were similar from an investment standpoint, but from a forward-looking perspective, they were very different.
  9. Mutual Funds & ETFs

    3 Vanguard Equity Fund Underperformers

    Discover three funds from Vanguard Group that consistently underperform their indexes. Learn how consistent most Vanguard low-fee funds are at matching their indexes.
  10. Investing News

    Alphabet Earnings Beat Expectations (GOOGL, AAPL)

    Alphabet's earnings crush analysts' expectations; now bigger than Apple?
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center